This Amendment No. 1 to Schedule 13D (this “Amendment No. 1”) is being filed jointly by Crixus BH3 Sponsor LLC, BH3 Management LLC, Mr. Daniel Lebensohn and Mr. Gregory Freedman (each a “Reporting Person” and collectively, the “Reporting Persons”) and amends and supplements the Schedule 13D filed jointly by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on October 16, 2023 (the “Original 13D”). This Amendment No. 1 is being filed pursuant to the Joint Filing Agreement as executed by the Reporting Persons, previously filed as Exhibit 1 to the Original 13D, and incorporated herein by reference.
Item 4. | Purpose of Transaction. |
Item 4 is hereby amended to incorporate the information contained in Item 6.
Item 5. | Interest in Securities of the Issuer. |
Items 5(a), (b) and (c) are hereby amended and restated as follows:
(a) and (b) The information contained on the cover pages to this Amendment No. 1 is incorporated herein by reference.
(c) The Reporting Persons effected the following transaction during the last 60 days:
Pursuant to the terms of the Purchase Agreement (as defined below), as of November 2, 2023, the Sponsor transferred 2,200,940 shares of Class A Common Stock and 578,191 shares of Class B Common Stock to Focus Impact BHAC Sponsor, LLC (as defined below).
Item 6. | Contracts, Arrangements, Understandings or Relationships with Respect to the Securities of the Issuer. |
The first paragraph of Item 6 is hereby amended and supplemented as follows:
Purchase Agreement
On September 27, 2023, the Issuer, the Sponsor and Focus Impact BHAC Sponsor, LLC (the “New Sponsor”) entered into a purchase agreement (the “Purchase Agreement”) pursuant to which, subject to satisfaction of certain conditions, the New Sponsor (i) agreed to purchase an aggregate of 3,746,303 shares of the Issuer’s common stock from the Sponsor and each of the anchor investors and 4,160,000 Private Placement Warrants from the Sponsor for an aggregate purchase price of $16,288.27 and (ii) become the sponsor of the Issuer (together, the “Purchase”).
The Purchase closed as of November 2, 2023. In connection with the closing of the Purchase, the Sponsor transferred 2,200,940 shares of Class A Common Stock, 578,191 shares of Class B Common Stock and 4,160,000 private placement warrants and the anchor investors transferred an aggregate of 967,172 shares of Class B Common Stock to the New Sponsor. Therefore, as of the date hereof, each of the Reporting Persons beneficially owns 1,360,111 shares of Class A Common Stock of the Issuer. In connection with the transactions contemplated by the Purchase Agreement, upon the request of an anchor investor, the Sponsor agreed to pay the requesting anchor investor $0.0043 per share.
In addition, in connection with the closing of the Purchase, (i) the New Sponsor (x) paid certain expenses, up to a mutually-agreed upon maximum, incurred by the Company, Sponsor and New Sponsor in connection with the Purchase and (y) reimbursed the Sponsor for the most recent extension payment made to the trust account established by the Company in the amount of $175,440.72, (ii) each of the (x) “working capital” promissory note between the Company and the Sponsor dated November 1, 2022 (in aggregate principal amount of approximately $910,000) and (y) “extension” promissory note between the Company and the Sponsor dated July 31, 2023 (in aggregate principal amount of $350,881.44) were terminated and of no further force and effect and (iii) the Sponsor has agreed to forfeit up to 133,333 shares of Class A Common Stock in connection with the closing of the Company’s initial business combination (the “Business Combination”) to help offset certain expenses that the Company may incur and/or dilution that the Company may experience in connection with the closing of the Business Combination.